Home
Soleus Capital Master Fund reported a 4.7% stake in UroGen Pharma URGN · 2,185,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.7%
- Last report
- 5% · filed 25/06/16
- Shares held
- 2,185,000 sh
- Class
- Ordinary Shares, par value NIS 0.01 per share
- Stock
- UroGen Pharma URGN
- Event date
- 25/06/30
- Filed
- 25/08/05
4.7% stake · below 5%
- Stake
- 4.7%
- Last report
- 5%
- Since last report
- −0.3pp
UroGen Pharma trades, last 26 weeks
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Soleus Capital Master Fund's other 5% stake reports
- Soleus Capital Master Fund
5% stakeEvolus
5% stakeEvolus
EOLS
5.3% stake
3,480,000 sh
5.3% stake
Filed 08/31
- Soleus Capital Master Fund
5% stakeProcessa Pharmaceuticals
5% stakeProcessa Pharmaceuticals
PCSA
5.8% stake
160,943 sh
5.8% stake
Filed 08/18
- Soleus Capital Master Fund
5% stakeInspire Medical Systems
5% stakeInspire Medical Systems
INSP
6.7% stake
1,931,436 sh
6.7% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakePalisade Bio
5% stakePalisade Bio
PALI
7.5% stake
13,063,687 sh
7.5% stake
Filed 08/13
- Soleus Capital Master Fund
5% stakeRigel Pharmaceuticals
5% stakeRigel Pharmaceuticals
RIGL
9.9% stake
1,843,504 sh
9.9% stake
Filed 08/13
